uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted February 01, 2018

Seller of Supplements for Opiate Withdrawal Warned for Drug Claims

On January 11, 2018, the FDA sent warning letters to ten sellers of supplements promoted to treat opiate withdrawal following reviews of the companies' websites and social media which found statements and testimonials made about the products to be drug claims.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at